grepcent public filings, reorganized for comparison

FLEXSTEEL INDUSTRIES INC (FLXS)

CIK: 0000037472. SIC: 2510 Household Furniture. Latest 10-K as of: 2026-08-19.

SIC breadcrumb: Manufacturing > SIC Major Group 25 > SIC 2510 Household Furniture

SEC company page: https://www.sec.gov/edgar/browse/?CIK=37472. Latest filing source: 0001193125-26-357097.

Informational only. Descriptive public-record data — not a rating, forecast, or investment advice. See Disclaimer.

At a glance

FY2026 · period end 2026-06-30 · filed 2026-08-19 · accession 0001193125-26-357097 · source: SEC companyfacts

Revenue
459,178,000 USD verified
Net income
33,128,000 USD verified
Assets
254,009,000 USD verified
Free cash flow
47,576,000 USD computed
Net margin
7.21% computed
Operating margin
9.27% computed
Revenue YoY
+4.10% computed
ROE
24.82% computed

Computed values are grepcent-computed from the verified facts above and may differ from ratios the company itself reports. Free cash flow = operating cash flow − capital expenditures. Net margin = net income ÷ revenue. Operating margin = operating income ÷ revenue. Revenue YoY = FY2026 revenue ÷ FY2025 revenue − 1 (consecutive fiscal years only). ROE = net income ÷ period-end stockholders' equity.

No market price, no rating, no forecast on this site. Not investment advice.

Peer & cluster context

Peer percentile fingerprint

FLXS ratios vs SIC peers. Source: grepcent computed from latest SEC companyfacts ratios; peer set SIC major-group 25; per-ratio N printed.FLXS ratios vs SIC peers. Source: grepcent computed from latest SEC companyfacts ratios; peer set SIC major-group 25; per-ratio N printed.RatioFLXSPeer medianPercentileNNet margin7.2%2.4%10011Operating margin9.3%4.8%8910Revenue growth4.1%1.6%6011FCF margin10.4%6.0%10011ROE24.8%6.8%10011ROA13.0%2.3%10011Liabilities / equity0.901.312011Current ratio2.091.897011

Percentile = share of the N covered peers reporting that ratio whose value is lower (ties counted half); computed among grepcent-covered companies in SIC major-group 25 SIC Major Group 25, not the whole market. A higher percentile means a higher value of the ratio, not a better company. Ratios with fewer than 8 reporting peers are omitted. Latest reported values per company; fiscal periods may differ. Descriptive arithmetic - not a score, rating, or ranking.

Selected Fundamentals

MetricValueUnitFYFiled
Revenue459,178,000USD20262026-08-19
Net income33,128,000USD20262026-08-19
Assets254,009,000USD20262026-08-19

Financials

Annual standardized facts from SEC companyfacts as of latest extracted filing date 2026-08-19. Source: https://data.sec.gov/api/xbrl/companyfacts/CIK0000037472.json. Derived margins, ratios, and free cash flow are computed from the extracted annual SEC facts.

Download these verified figures (annual + quarterly, with per-value filing provenance): JSON · CSV

Flow metrics use full-year FY periods from 10-K/10-K/A filings; balance-sheet metrics use FY-end instants. Free cash flow = operating cash flow - capital expenditures. Missing metrics are omitted rather than fabricated.

Metric2017201820192020202120222023202420252026
Revenue468,764,000489,180,000443,588,000366,926,000478,925,000544,282,000393,692,000412,752,000441,073,000459,178,000
Net income23,786,00017,666,000-32,605,000-26,844,00023,048,0001,853,00014,778,00010,528,00020,154,00033,128,000
Operating income37,264,00024,505,000-43,154,000-34,395,00031,200,0006,617,00010,542,00017,080,00026,615,00042,550,000
Gross profit108,651,00098,219,00069,940,00053,053,00096,730,00072,680,00070,947,00087,244,00097,944,000113,436,000
Diluted EPS3.022.23-4.13-3.373.090.282.741.913.556.07
Operating cash flow26,388,00027,294,0006,714,00018,287,000-32,692,0007,993,00022,989,00031,883,00036,979,00051,517,000
Capital expenditures13,457,00029,447,00021,346,0003,688,0002,580,0003,853,0004,790,0004,772,0003,258,0003,941,000
Dividends paid6,062,0006,746,0006,918,0007,022,0002,622,0003,911,0003,241,0003,219,0003,556,0004,375,000
Assets270,045,000284,293,000254,287,000237,259,000296,779,000268,741,000290,550,000274,462,000282,486,000254,009,000
Liabilities39,285,00042,595,00048,860,00061,754,000128,811,000137,181,000148,929,000124,095,000114,624,000120,514,000
Stockholders' equity230,760,000241,698,000205,427,000175,505,000167,968,000131,560,000141,621,000150,367,000167,862,000133,495,000
Cash and cash equivalents28,874,00027,750,00022,247,00048,197,0001,342,0002,184,0003,365,0004,761,00040,006,00016,678,000
Free cash flow12,931,000-2,153,000-14,632,00014,599,000-35,272,0004,140,00018,199,00027,111,00033,721,00047,576,000

Ratios

ROE and ROA use period-end equity/assets. Liabilities / equity uses total liabilities divided by stockholders' equity. Current ratio uses current assets divided by current liabilities when both are reported.

Metric2017201820192020202120222023202420252026
Net margin5.07%3.61%-7.35%-7.32%4.81%0.34%3.75%2.55%4.57%7.21%
Operating margin7.95%5.01%-9.73%-9.37%6.51%1.22%2.68%4.14%6.03%9.27%
Return on equity10.31%7.31%-15.87%-15.30%13.72%1.41%10.43%7.00%12.01%24.82%
Return on assets8.81%6.21%-12.82%-11.31%7.77%0.69%5.09%3.84%7.13%13.04%
Liabilities / equity0.170.180.240.350.771.041.050.830.680.90
Current ratio5.254.633.473.402.292.943.102.572.782.09

Industry Peer Context

Each number-line places FLXS against the min, median, and max of latest reported values among companies in the same SIC industry when at least three peers report that ratio.

Net margin peer context

FLXS Net margin versus SIC peer range. Source: grepcent computed from latest SEC companyfacts ratios for SIC industry 2510; peer count 5.FLXS Net margin versus SIC peer range. Source: grepcent computed from latest SEC companyfacts ratios for SIC industry 2510; peer count 5.5 SIC peersMin -12.1%Median 5.1%Max 7.2%FLXS 7.2%

Operating margin peer context

FLXS Operating margin versus SIC peer range. Source: grepcent computed from latest SEC companyfacts ratios for SIC industry 2510; peer count 4.FLXS Operating margin versus SIC peer range. Source: grepcent computed from latest SEC companyfacts ratios for SIC industry 2510; peer count 4.4 SIC peersMin 0.6%Median 7.7%Max 10.1%FLXS 9.3%

ROE peer context

FLXS ROE versus SIC peer range. Source: grepcent computed from latest SEC companyfacts ratios for SIC industry 2510; peer count 5.FLXS ROE versus SIC peer range. Source: grepcent computed from latest SEC companyfacts ratios for SIC industry 2510; peer count 5.5 SIC peersMin -51.2%Median 12.4%Max 24.8%FLXS 24.8%

ROA peer context

FLXS ROA versus SIC peer range. Source: grepcent computed from latest SEC companyfacts ratios for SIC industry 2510; peer count 5.FLXS ROA versus SIC peer range. Source: grepcent computed from latest SEC companyfacts ratios for SIC industry 2510; peer count 5.5 SIC peersMin -7.4%Median 5.0%Max 13.0%FLXS 13.0%

Financial Bridges

Waterfall figures reconcile reported SEC companyfacts components. Missing bridges are omitted when required components are not present for the same fiscal year.

Income statement bridge from reported figures

FLXS FY2026 income statement bridge from reported figures.FLXS FY2026 income statement bridge from reported figures.FLXS income bridgeFY2026: revenue to net incomeSource: SEC companyfacts FY2026.Income statement bridgeReported amount$0.0B$250.0M$500.0M$459.2MRevenue-$345.7MCost$113.4MGross-$70.9MOpEx$42.5MOperating-$9.4MOther/tax$33.1MNet income

Figure provenance: SEC companyfacts FY 2026. Revenue: accession 0001193125-26-357097; concept RevenueFromContractWithCustomerExcludingAssessedTax; source concepts us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax | Gross profit: accession 0001193125-26-357097; concept GrossProfit; source concepts us-gaap:GrossProfit | Operating income: accession 0001193125-26-357097; concept OperatingIncomeLoss; source concepts us-gaap:OperatingIncomeLoss | Net income: accession 0001193125-26-357097; concept NetIncomeLoss; source concepts us-gaap:NetIncomeLoss

Free cash flow = operating cash flow - capital expenditures

FLXS FY2026 free cash flow bridge from reported figures.FLXS FY2026 free cash flow bridge from reported figures.FLXS free cash flow bridgeFY2026: operating cash flow less capital expendituresSource: SEC companyfacts FY2026.Free cash flow bridgeReported amount$0.0B$125.0M$250.0M$51.5MOperating cash flow-$3.9MCapex$47.6MFree cash flow

Figure provenance: SEC companyfacts FY 2026. Operating cash flow: accession 0001193125-26-357097; concept NetCashProvidedByUsedInOperatingActivities; source concepts us-gaap:NetCashProvidedByUsedInOperatingActivities | Capital expenditures: accession 0001193125-26-357097; concept PaymentsToAcquirePropertyPlantAndEquipment; source concepts us-gaap:PaymentsToAcquirePropertyPlantAndEquipment | Free cash flow: accession 0001193125-26-357097; concept NetCashProvidedByUsedInOperatingActivities - PaymentsToAcquirePropertyPlantAndEquipment; source concepts us-gaap:NetCashProvidedByUsedInOperatingActivities; us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

Financial Charts

FLXS revenue, last 5 periods. Source: SEC companyfacts FY2026.FLXS revenue, last 5 periods. Source: SEC companyfacts FY2026.FLXS RevenueLatest point: FY2026 = $459.2MSource: SEC companyfacts FY2026.Fiscal yearReported revenue$0.0B$375.0M$750.0MFY2022FY2023FY2024FY2025FY2026

Figure provenance: SEC companyfacts. Latest point: FY 2026 ended 2026-06-30; accession 0001193125-26-357097; filed 2026-08-19. Concept: RevenueFromContractWithCustomerExcludingAssessedTax. Source concepts: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

FLXS net income, last 5 periods. Source: SEC companyfacts FY2026.FLXS net income, last 5 periods. Source: SEC companyfacts FY2026.FLXS Net incomeLatest point: FY2026 = $33.1MSource: SEC companyfacts FY2026.Fiscal yearNet income$0.0B$125.0M$250.0MFY2022FY2023FY2024FY2025FY2026

Figure provenance: SEC companyfacts. Latest point: FY 2026 ended 2026-06-30; accession 0001193125-26-357097; filed 2026-08-19. Concept: NetIncomeLoss. Source concepts: us-gaap:NetIncomeLoss.

FLXS operating income, last 5 periods. Source: SEC companyfacts FY2026.FLXS operating income, last 5 periods. Source: SEC companyfacts FY2026.FLXS Operating incomeLatest point: FY2026 = $42.5MSource: SEC companyfacts FY2026.Fiscal yearOperating income$0.0B$125.0M$250.0MFY2022FY2023FY2024FY2025FY2026

Figure provenance: SEC companyfacts. Latest point: FY 2026 ended 2026-06-30; accession 0001193125-26-357097; filed 2026-08-19. Concept: OperatingIncomeLoss. Source concepts: us-gaap:OperatingIncomeLoss.

FLXS gross profit, last 5 periods. Source: SEC companyfacts FY2026.FLXS gross profit, last 5 periods. Source: SEC companyfacts FY2026.FLXS Gross profitLatest point: FY2026 = $113.4MSource: SEC companyfacts FY2026.Fiscal yearGross profit$0.0B$125.0M$250.0MFY2022FY2023FY2024FY2025FY2026

Figure provenance: SEC companyfacts. Latest point: FY 2026 ended 2026-06-30; accession 0001193125-26-357097; filed 2026-08-19. Concept: GrossProfit. Source concepts: us-gaap:GrossProfit.

FLXS diluted eps, last 5 periods. Source: SEC companyfacts FY2026.FLXS diluted eps, last 5 periods. Source: SEC companyfacts FY2026.FLXS Diluted EPSLatest point: FY2026 = $6.07/shareSource: SEC companyfacts FY2026.Fiscal yearDiluted EPS (USD/share)$0.00/share$4.00/share$8.00/shareFY2022FY2023FY2024FY2025FY2026

Figure provenance: SEC companyfacts. Latest point: FY 2026 ended 2026-06-30; accession 0001193125-26-357097; filed 2026-08-19. Concept: EarningsPerShareDiluted. Source concepts: us-gaap:EarningsPerShareDiluted.

FLXS operating cash flow, last 5 periods. Source: SEC companyfacts FY2026.FLXS operating cash flow, last 5 periods. Source: SEC companyfacts FY2026.FLXS Operating cash flowLatest point: FY2026 = $51.5MSource: SEC companyfacts FY2026.Fiscal yearOperating cash flow$0.0B$125.0M$250.0MFY2022FY2023FY2024FY2025FY2026

Figure provenance: SEC companyfacts. Latest point: FY 2026 ended 2026-06-30; accession 0001193125-26-357097; filed 2026-08-19. Concept: NetCashProvidedByUsedInOperatingActivities. Source concepts: us-gaap:NetCashProvidedByUsedInOperatingActivities.

FLXS capital expenditures, last 5 periods. Source: SEC companyfacts FY2026.FLXS capital expenditures, last 5 periods. Source: SEC companyfacts FY2026.FLXS Capital expendituresLatest point: FY2026 = $3.9MSource: SEC companyfacts FY2026.Fiscal yearCapital expenditures$0.0B$125.0M$250.0MFY2022FY2023FY2024FY2025FY2026

Figure provenance: SEC companyfacts. Latest point: FY 2026 ended 2026-06-30; accession 0001193125-26-357097; filed 2026-08-19. Concept: PaymentsToAcquirePropertyPlantAndEquipment. Source concepts: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

FLXS dividends paid, last 5 periods. Source: SEC companyfacts FY2026.FLXS dividends paid, last 5 periods. Source: SEC companyfacts FY2026.FLXS Dividends paidLatest point: FY2026 = $4.4MSource: SEC companyfacts FY2026.Fiscal yearDividends paid$0.0B$125.0M$250.0MFY2022FY2023FY2024FY2025FY2026

Figure provenance: SEC companyfacts. Latest point: FY 2026 ended 2026-06-30; accession 0001193125-26-357097; filed 2026-08-19. Concept: PaymentsOfDividends. Source concepts: us-gaap:PaymentsOfDividends.

FLXS assets, last 5 periods. Source: SEC companyfacts FY2026.FLXS assets, last 5 periods. Source: SEC companyfacts FY2026.FLXS AssetsLatest point: FY2026 = $254.0MSource: SEC companyfacts FY2026.Fiscal yearAssets$0.0B$250.0M$500.0MFY2022FY2023FY2024FY2025FY2026

Figure provenance: SEC companyfacts. Latest point: FY 2026 ended 2026-06-30; accession 0001193125-26-357097; filed 2026-08-19. Concept: Assets. Source concepts: us-gaap:Assets.

FLXS liabilities, last 5 periods. Source: SEC companyfacts FY2026.FLXS liabilities, last 5 periods. Source: SEC companyfacts FY2026.FLXS LiabilitiesLatest point: FY2026 = $120.5MSource: SEC companyfacts FY2026.Fiscal yearLiabilities$0.0B$125.0M$250.0MFY2022FY2023FY2024FY2025FY2026

Figure provenance: SEC companyfacts. Latest point: FY 2026 ended 2026-06-30; accession 0001193125-26-357097; filed 2026-08-19. Concept: Liabilities. Source concepts: us-gaap:Liabilities.

FLXS stockholders' equity, last 5 periods. Source: SEC companyfacts FY2026.FLXS stockholders' equity, last 5 periods. Source: SEC companyfacts FY2026.FLXS Stockholders' equityLatest point: FY2026 = $133.5MSource: SEC companyfacts FY2026.Fiscal yearStockholders' equity$0.0B$125.0M$250.0MFY2022FY2023FY2024FY2025FY2026

Figure provenance: SEC companyfacts. Latest point: FY 2026 ended 2026-06-30; accession 0001193125-26-357097; filed 2026-08-19. Concept: StockholdersEquity. Source concepts: us-gaap:StockholdersEquity.

FLXS cash and cash equivalents, last 5 periods. Source: SEC companyfacts FY2026.FLXS cash and cash equivalents, last 5 periods. Source: SEC companyfacts FY2026.FLXS Cash and cash equivalentsLatest point: FY2026 = $16.7MSource: SEC companyfacts FY2026.Fiscal yearCash and cash equivalents$0.0B$125.0M$250.0MFY2022FY2023FY2024FY2025FY2026

Figure provenance: SEC companyfacts. Latest point: FY 2026 ended 2026-06-30; accession 0001193125-26-357097; filed 2026-08-19. Concept: CashAndCashEquivalentsAtCarryingValue. Source concepts: us-gaap:CashAndCashEquivalentsAtCarryingValue.

FLXS free cash flow, last 5 periods. Source: SEC companyfacts FY2026.FLXS free cash flow, last 5 periods. Source: SEC companyfacts FY2026.FLXS Free cash flowLatest point: FY2026 = $47.6MSource: SEC companyfacts FY2026.Fiscal yearFree cash flow$0.0B$125.0M$250.0MFY2022FY2023FY2024FY2025FY2026

Figure provenance: SEC companyfacts. Latest point: FY 2026 ended 2026-06-30; accession 0001193125-26-357097; filed 2026-08-19. Concept: NetCashProvidedByUsedInOperatingActivities - PaymentsToAcquirePropertyPlantAndEquipment. Source concepts: us-gaap:NetCashProvidedByUsedInOperatingActivities; us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

As-reported value updates

No tracked differences above grepcent's stated thresholds and capped precision rule were found between the earliest XBRL-filed value and the value currently on file for the standardized annual metrics grepcent tracks.

Quarterly

Quarterly standardized facts from SEC companyfacts as of latest extracted filing date 2026-04-22. Source: https://data.sec.gov/api/xbrl/companyfacts/CIK0000037472.json.

Flow metrics use discrete quarter-length periods from 10-Q/10-Q/A filings. Q4 revenue and net income are derived only when annual FY and nine-month YTD facts exist for the same fiscal year; derived Q4 values are labeled. EPS Q4 is not derived.

QuarterEnd DateRevenueNet IncomeDiluted EPSMethod
2022-Q12021-09-300.61reported discrete quarter
2022-Q22021-12-31-1.13reported discrete quarter
2022-Q32022-03-310.82reported discrete quarter
2022-Q42022-06-30124,517,000-271,000derived Q4 = FY annual - nine-month YTD
2023-Q22022-09-30289,000reported discrete quarter
2023-Q22022-12-3193,137,0000.53reported discrete quarter
2023-Q32022-12-312,853,000reported discrete quarter
2023-Q32023-03-3199,052,0000.28reported discrete quarter
2023-Q42023-06-30105,819,00010,161,000derived Q4 = FY annual - nine-month YTD
2023-Q12023-09-3094,603,000752,0000.14reported discrete quarter
2024-Q22023-09-30752,000reported discrete quarter
2024-Q22023-12-31100,108,0000.57reported discrete quarter
2024-Q32023-12-313,051,000reported discrete quarter
2024-Q32024-03-31107,219,0000.33reported discrete quarter
2024-Q42024-06-30110,822,0004,922,000derived Q4 = FY annual - nine-month YTD
2024-Q12024-09-30104,007,0004,140,0000.74reported discrete quarter
2025-Q12025-09-30110,439,0007,327,0001.31reported discrete quarter
2025-Q22025-09-307,327,000reported discrete quarter
2025-Q22025-12-31118,249,0001.18reported discrete quarter
2025-Q32025-12-316,644,000reported discrete quarter
2025-Q32026-03-31115,125,0001.14reported discrete quarter

Quarterly Charts

FLXS quarterly revenue, last 12 periods. Source: SEC companyfacts 2025-Q3.FLXS quarterly revenue, last 12 periods. Source: SEC companyfacts 2025-Q3.FLXS Quarterly RevenueLatest point: 2025-Q3 = $115.1MSource: SEC companyfacts 2025-Q3.Fiscal quarterQuarterly Revenue$0.0B$125.0M$250.0M2022-Q42023-Q22023-Q32023-Q42023-Q12024-Q22024-Q32024-Q42024-Q12025-Q12025-Q22025-Q3

Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2026-03-31; accession 0001193125-26-170444; filed 2026-04-22. Concept: RevenueFromContractWithCustomerExcludingAssessedTax. Source concepts: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

FLXS quarterly net income, last 12 periods. Source: SEC companyfacts 2025-Q3.FLXS quarterly net income, last 12 periods. Source: SEC companyfacts 2025-Q3.FLXS Quarterly Net incomeLatest point: 2025-Q3 = $6.6MSource: SEC companyfacts 2025-Q3.Fiscal quarterQuarterly Net income-$250.0M$0.0B$250.0M2022-Q42023-Q22023-Q32023-Q42023-Q12024-Q22024-Q32024-Q42024-Q12025-Q12025-Q22025-Q3

Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-12-31; accession 0001193125-26-170444; filed 2026-04-22. Concept: NetIncomeLoss. Source concepts: us-gaap:NetIncomeLoss.

FLXS quarterly diluted eps, last 12 periods. Source: SEC companyfacts 2025-Q3.FLXS quarterly diluted eps, last 12 periods. Source: SEC companyfacts 2025-Q3.FLXS Quarterly Diluted EPSLatest point: 2025-Q3 = $1.14/shareSource: SEC companyfacts 2025-Q3.Fiscal quarterQuarterly Diluted EPS (USD/share)-$1.50/share$0.00/share$2.00/share2022-Q12022-Q22022-Q32023-Q22023-Q32023-Q12024-Q22024-Q32024-Q12025-Q12025-Q22025-Q3

Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2026-03-31; accession 0001193125-26-170444; filed 2026-04-22. Concept: EarningsPerShareDiluted. Source concepts: us-gaap:EarningsPerShareDiluted.

Business

Read FLXS's verbatim Item 1 Business section from its latest 10-K: Business.

Risk Factors

Read FLXS's verbatim Item 1A Risk Factors from its latest 10-K: Risk Factors.

Latest quarter (10-Q)

Latest 10-Q source: 0001193125-26-170444.

Extracted structurally from real Item 2 body heading to real Item 3/4 boundary. Confidence: high. Filing date: 2026-04-22. Report date: 2026-03-31.

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

GENERAL

The following analysis of the results of operations and financial condition of the Company should be read in conjunction with the Consolidated Financial Statements and related notes included elsewhere in this quarterly report on Form 10-Q.

CRITICAL ACCOUNTING POLICIES:

There have been no material changes to our critical accounting policies and estimates from the information provided in Item 7, "Management's Discussion and Analysis of Financial Condition and Results of Operations", included in our 2025 annual report on Form 10-K.

Overview

The following table has been prepared as an aid in understanding the Company’s results of operations on a comparative basis for the three and nine months ended March 31, 2026 and 2025. The amounts presented are percentages of the Company’s net sales.

Three Months EndedNine Months Ended
March 31,March 31,
2026202520262025
Net sales100.0%100.0%100.0%100.0%
Cost of goods sold77.477.877.178.4
Gross margin22.622.222.921.6
Selling, general and administrative expenses15.515.015.315.2
Right-of-use asset impairment—12.4—4.3
(Gain) on sale of real estate—(0.7)—(0.2)
(Gain) on disposal of assets held for sale———(1.5)
Operating income (loss)7.1(4.4)7.63.8
Interest income0.30.10.3—
Income (loss) before income taxes7.4(4.3)7.93.8
Income tax provision (benefit)1.9(1.1)2.01.0
Net income (loss) and comprehensive income5.6%(3.3)%5.9%2.8%

Results of Operations for the Quarter Ended March 31, 2026 vs. 2025

Net sales were $115.1 million for the quarter ended March 31, 2026, compared to net sales of $114.0 million in the prior year quarter, an increase of 1.0%. The increase was driven by higher pricing from tariff surcharges, offset by lower unit volume, particularly in our made-to-order, ready-to-assemble and case goods categories.

Sales order backlog, inclusive of estimated tariff surcharges, was $79.5 million as of the quarter ended March 31, 2026, an increase of 1.5% compared to $78.3 million in the prior year quarter.

Gross margin as a percent of net sales for the quarter ended March 31, 2026, was 22.6%, compared to 22.2% for the prior year quarter, an increase of 40 basis points (“bps”). The 40-bps increase was primarily driven by favorable sales composition of higher margin products.

Selling, general and administrative (“SG&A”) expenses increased $0.7 million to $17.8 million in the quarter ended March 31, 2026, as compared to $17.1 million in the prior year quarter. As a percentage of net sales, SG&A was 15.5% in the quarter ended March 31, 2026 compared to 15.0% of net sales in the prior year quarter. The 50-bps increase was mainly due to investments in consumer insights, innovation, demand generation, and customer experience.

Income tax expense was $2.1 million, or an effective rate of 24.9% for the quarter ended March 31, 2026, compared to income tax benefit of ($1.2) million, or an effective rate of 24.5% for the quarter ended March 31, 2025. For the quarter ended March 31, 2026, the effective tax rate differs from the statutory tax rate of 21% primarily due to state taxes, the impact of foreign operations, and non-deductible compensation offset by credits for research and development.

13

Table of Contents

Net income was $6.4 million, or $1.14 per diluted share for the quarter ended March 31, 2026, compared to net loss of ($3.7) million, or $(0.71) per diluted share in the prior year quarter. During the quarter ended March 31, 2025, the Company recorded a right-of-use asset impairment on the manufacturing facility in Mexicali, Mexico.

Results of Operations for the nine months ended March 31, 2026 and 2025

Net sales were $343.8 million for the nine months ended March 31, 2026, compared to net sales of $326.5 million in the prior-year nine-month period, an increase of 5.3%. The increase in sales of $17.3 million was driven by higher unit volume of sourced soft seating products and pricing from tariff surcharges, partially offset by lower unit volume in our made-to-order soft seating products and homestyles branded ready-to-assemble products.

Gross margin as a percent of net sales for the nine months ended March 31, 2026, was 22.9%, compared to 21.6% for the prior-year nine-month period, an increase of 130 bps. The 130-bps increase was primarily driven by favorable sales composition of higher margin products, partially offset by the dilutive impact of tariffs.

Selling, general and administrative expenses increased $3.1 million in the nine months ended March 31, 2026, compared to the prior-year nine-month period. SG&A as a percentage of sales was 15.3% in the nine months ended March 31, 2026, compared to the prior-year nine-month period of 15.2%. The 10-bps increase was mainly due to investments in growth initiatives.

Income tax expense was $6.9 million, or an effective rate of 25.2%, during the nine months ended March 31, 2026, compared to income tax expense of $3.3 million in the prior-year nine-month period, or an effective tax rate of 25.6%. The effective tax rate for the nine months ended March 31, 2026, was primarily impacted by state taxes, the impact of foreign operations and nondeductible compensation, offset by credits for research and development.

Net income was $20.4 million, or $3.63 per diluted share for the nine months ended March 31, 2026, compared to net income of $9.5 million, or $1.70 per diluted share in the prior-year nine-month period. During the nine-month period ended March 31, 2025, the Company recorded a right-of-use asset impairment on the manufacturing facility in Mexicali, Mexico. In addition the Company recorded pre-tax gains related to the sale of its Dublin, Georgia facility and an ancillary building, formerly part of its Huntingburg, IN distribution center.

Liquidity and Capital Resources

Working capital (current assets less current liabilities) on March 31, 2026, was $142.2 million compared to $110.4 million on June 30, 2025. The $31.8 million increase in working capital was primarily due to an increase in cash of $17.3 million, other current assets of $13.2 million, an increase in trade receivables of $6.2 million, and a decrease in accounts payable of $1.7 million, a decrease in other current liabilities of $1.6 million, a decrease in other current liabilities of $0.8 million partially offset by a decrease in inventories of $8.6 million and an increase in operating lease of $0.4. Refer to discussion of working capital changes below, under Net cash provided by operating activities. Capital expenditures were $3.5 million during the nine months ended March 31, 2026.

A summary of operating, investing, and financing cash flow is shown in the following table:

Nine Months Ended
March 31,
(in thousands)20262025
Net cash provided by operating activities$27,195$21,353
Net cash (used in) provided by investing activities(3,524)6,003
Net cash (used in) financing activities(6,394)(9,483)
Increase in cash and cash equivalents$17,277$17,873

Net cash provided by operating activities

For the nine months ended March 31, 2026, net cash provided by operating activities was $27.2 million, primarily due to net income of $20.4 million, a decrease in inventories of $8.6 million and adjustments for non-cash items including stock-based compensation of $3.4 million, deferred income taxes $3.3 million, depreciation of $2.8 million, provision for credit losses of $0.3 million, partially offset by an increase in trade receivables of $6.5 million, a decrease in accrued liabilities of $3.7 million, a decrease in accounts payable of $1.3 million and an increase in other current assets of $0.1 million.

For the nine months ended March 31, 2025, net cash provided by operating activities was $21.4 million, primarily due to net income of $9.5 million, adjustments for non-cash items including a right-of-use asset impairment of $14.1 million, a pre-tax gain on sale of assets of $5.8 million, deferred income tax of $3.5 million, stock-based compensation of $3.0 million, and depreciation of $2.8 million, as well

14

Table of Contents

as changes in operating assets and liabilities including, a decrease in inventory of $9.4 million, and a decrease in trade receivables of $5.8 million, offset by an increase in other assets of $5.6 million, a decrease in accounts payable of $3.7 million, a decrease in accrued liabilities of $3.5 million, an increase in other current assets of $1.3 and a decrease in other long-term liabilities of $0.2 million.

Net cash (used in) provided by investing activities

For the nine months ended March 31, 2026, net cash used in investing activities was $3.5 million due to capital expenditures.

For the nine months ended March 31, 2025, net cash provided by investing activities was $6.0 million due to proceeds from the sales of property, plant and equipment of $7.5 million, and corporate owned life insurance proceeds of $1.2 million, offset by capital expenditures of $2.7 million.

Net cash (used in) financing activities

For the nine months ended March 31, 2026, net cash used in financing activities was $6.4 million, primarily due to dividends paid of $3.3 million, shares withheld for tax payments on vested shares and options exercised of $2.0 million and treasury stock purchases of $1.1 million.

For the nine months ended March 31, 2025, net cash used in financing activities was $9.5 million, due to payments on the line of credit of $207.3 million, dividends paid of $2.7 million, and shares withheld for tax payments on vested shares and options exercised of $2.1 million, partially offset by proceeds from the line of credit of $202.3 million and proceeds from issuance of common stock of $0.1 million.

Line of Credit

On September 8, 2021, the Company, as the borrower, entered into a credit agreement (the “Credit Agreement”) with Wells Fargo Bank, National Association (the “Lender”), and the other lenders thereto. The Credit Agreement has a five-year term and provided for up to an $85 million revolving line of credit. Subject to certain conditions, the Credit Agreement also provides for the issuance of letters of credit in an aggregate amount up to $5 million which, upon issuance, would be deemed advances under the revolving line of credit. Proceeds of borrowings were used to refinance all indebtedness owed to a prior lender and for working capital purposes. The Company’s obligations under the Credit Agreement are secured by substantially all its assets, excluding real property. The Credit Agreement contains customary representations, warranties, and covenants, including a financial covenant to maintain a fixed coverage ratio of not less than 1.00 to 1.00. In addition, the Loan Agreement places restrictions on the Company’s ability to incur additional indebtedness, to create liens or other encumbrances, to sell or otherwise dispose of assets, and to merge or consolidate with other entitie

[Excerpt truncated for page length; source filing is linked above.]

Latest 10-K MD&A (excerpt)

Latest 10-K Item 7 source: 0001193125-26-357097. The complete FY 2026 MD&A is published at /company/FLXS/mda/fy2026/.

Extracted structurally from real Item 7 body heading to real Item 7A/8 boundary. Published MD&A gate trimmed front/tail over-capture. Confidence: high. Filing date: 2026-08-19. Report date: 2026-06-30.

Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations

General

The following analysis of the results of operations and financial condition of the Company should be read in conjunction with the consolidated financial statements and related notes included elsewhere in this Annual Report on Form 10-K.

Results of Operations

The following table has been prepared as an aid in understanding the Company’s results of operations on a comparative basis for the fiscal years ended June 30, 2026, 2025, and 2024. Amounts presented are percentages of the Company’s net sales.

For the years ended June 30,
202620252024
Net sales100.0%100.0%100.0%
Cost of goods sold75.377.878.9
Gross margin24.722.221.1
Selling, general and administrative expenses15.415.117.1
Restructuring expense——0.7
Right-of-use asset impairment—3.2—
(Gain) on sale of real estate—(0.2)—
(Gain) on disposal of assets held for sale—(2.0)(0.8)
Operating income9.36.04.1
Interest income0.30.10.0
Interest (expense)——(0.4)
Income before income taxes9.56.13.8
Income tax provision2.31.51.2
Net income and comprehensive income7.2%4.6%2.6%

Fiscal 2026 Compared to Fiscal 2025

Net sales were $459.2 million for the year ended June 30, 2026, compared to net sales of $441.1 million in the prior year, an increase of $18.1 million or 4.1%. The increase in sales was primarily driven by $28.0 million of growth in soft seating products, partially offset by a $9.0 million decline in homestyles branded ready-to-assemble product sales and $0.9 million decline in Flexsteel branded casegoods.

Gross margin for the year ended June 30, 2026, was 24.7%, compared to 22.2% for the prior fiscal year, an increase of 250 basis points (“bps”). The 250-bps increase was primarily driven by a 200-bps benefit from the International Emergency Economic Powers Act ("IEEPA") Tariff Refunds received and to a lesser extent favorable mix driven by product and customer portfolio optimization initiatives.

Selling, general, and administrative (“SG&A”) expenses increased by $4.2 million in the year ended June 30, 2026, compared to the prior fiscal year. As a percentage of net sales, SG&A expense was 15.4% in fiscal year 2026 compared to 15.1% of net sales in the prior fiscal year. The increase of 30-bps is primarily due to a 70-bps benefit from fixed cost leverage on higher sales volume offset by 70-bps increase in investments in consumer insights, new products and marketing to execute our growth strategy and a 30-bps increase from higher incentive compensation expense.

Income tax expense was $10.7 million, or an effective rate of 24.4%, for the year ended June 30, 2026, compared to income tax expense of $6.8 million in the prior year, or an effective tax rate of 25.3%. The current year effective tax rate was primarily impacted by lower non-deductible compensation, effect of state and foreign taxes, partially offset by stock-based compensation and a research and development credit benefit. The prior year tax rate was primarily impacted by the effect of state and foreign taxes, offset by a research and development credit benefit. The Company adjusted its provision for income tax and measurement of deferred tax assets in accordance with the One Big Beautiful Act ("OBBBA"). See Note 10, Income Taxes, of the Notes to Consolidated Financial Statements, included in this Annual Report on Form 10-K for more information.

Net income was $33.1 million, or $6.07 per diluted share for the year ended June 30, 2026, compared to net income of $20.2 million, or $3.55 per diluted share in the prior year.

On July 31, 2025, the President of the United States issued an executive order intended to clarify certain matters related to previously issued executive orders on tariffs. This executive order included, among other things, an increase in the country specific tariff from 10%

13

Table of Contents

to 20% on goods imported from Vietnam. Accordingly, both our seating and case goods products sourced from Vietnam were subject to tariffs under IEEPA during this period. In addition, beginning in October 2025, substantially all of the seating products we source from Vietnam and manufacture in Mexico became subject to a 25% tariff under Section 232 of the Trade Expansion Act of 1962 pursuant to the Presidential Proclamation Adjusting Imports of Timber, Lumber, and their Derivative Products into the United States. For these seating products, the Section 232 tariff superseded the previously applicable IEEPA tariffs. Our case goods products sourced from Vietnam continued to be subject to the applicable IEEPA tariffs until February 2026, when the U.S. Supreme Court held that the tariffs imposed under IEEPA exceeded the authority granted under that statute. Following the Supreme Court's decision, a temporary 10% global import surcharge was imposed under Section 122 of the Trade Act of 1974 and became applicable to our case goods products sourced from Vietnam. On July 24, 2026, the U.S. implemented a new tariff framework under Section 301 of the Trade Act of 1974. The new framework imposes tariffs of either 10% or 12.5% on imports from certain trading partners, including Vietnam. This Section 301 tariff applies to bedroom, dining and occasional casegood products we source from Vietnam. The majority of our seating products sourced from Vietnam and manufactured in Mexico remain subject to the 25% Section 232 tariffs which, under the existing proclamation, is scheduled to increase to 30% effective January 1, 2027, unless modified prior to that date, and are generally not subject to the additional Section 301 tariffs. In addition, as a result of the U.S. Supreme Court's February 2026 decision regarding the IEEPA tariff program, the U.S. Court of International Trade ordered the U.S. government to process refunds of tariffs collected under the IEEPA tariff program. These refunds relate only to tariffs imposed under the IEEPA authority and do not affect the Section 232 tariffs that continue to apply to the majority of the Company's upholstered seating products.

Fiscal 2025 Compared to Fiscal 2024

Net sales were $441.1 million for the year ended June 30, 2025, compared to net sales of $412.8 million in the prior year, an increase of $28.3 million or 6.9%. The increase in sales was primarily driven by unit volume in our soft seating products, offset by a decline in our homestyles ready-to-assemble product line.

Gross margin for the year ended June 30, 2025, was 22.2%, compared to 21.1% for the prior fiscal year, an increase of 110 basis points (“bps”). The 110-bps increase was primarily driven by fixed cost leverage on higher sales, supply chain cost savings, and product portfolio management.

Selling, general, and administrative (“SG&A”) expenses decreased by $3.7 million in the year ended June 30, 2025, compared to the prior fiscal year. As a percentage of net sales, SG&A expense was 15.1% in fiscal year 2025 compared to 17.1% of net sales in the prior fiscal year. The decrease of 200-bps is primarily due to fixed cost leverage on higher sales volume and structural cost savings partially offset by investments in growth initiatives. The prior year SG&A expense also included a $1.5 million expense due to CEO transition costs associated with the revaluation of previously awarded equity awards which did not recur in the year ended June 30, 2025.

In July 2022, Flexsteel commenced a 12-year lease for a manufacturing facility in Mexicali, Mexico to support strong demand growth which was elevated due to pandemic-driven buying at that time. Subsequently, U.S. furniture demand reverted to pre-pandemic norms, and the Company’s plan for the facility pivoted to subleasing the space short-term while maintaining the option to utilize it longer term to support growth. While the Company secured multiple short-term sublease tenants at the beginning of the lease term, substantial changes in U.S. trade policy in early 2025 created significant uncertainty in US-Mexico trade relations, slowed foreign direct investment in Mexico, and greatly diminished tenant interest in subleasing the Mexicali facility. As a result, management concluded that the right of use asset related to this lease was not fully recoverable and recorded a pre-tax non-cash asset impairment charge of $14.1 million during the quarter ended March 31, 2025. See Note 2, Leases, of the Notes to Consolidated Financial Statements, included in this Annual Report on Form 10-K for more information.

During the year ended June 30, 2025, the Company completed the sale of its Dublin, Georgia facility which had been previously recorded as held for sale. The Company recorded a pre-tax gain of $5.0 million related to the sale. See Note 6, Assets Held For Sale, of the Notes to Consolidated Financial Statements, included in this Annual Report on Form 10-K for more information.

During the year ended June 30, 2025, the Company completed the sale of 2 separate ancillary buildings, formerly part of its Huntingburg, Indiana distribution center complex. The Company received proceeds of $0.8 million and recorded a pre-tax gain of $0.7 million related to the first sale. The Company received proceeds of $4.0 million and recorded a pre-tax gain of $3.7 million related to the second sale. The Company has adequate distribution capacity to support our growth as we continue to optimize our distribution and logistics network. See Note 6, Assets Held For Sale, of the Notes to Consolidated Financial Statements, included in this Annual Report on Form 10-K for more information.

Income tax expense was $6.8 million, or an effective rate of 25.3%, for the year ended June 30, 2025, compared to income tax expense of $5.0 million in the prior year, or an effective tax rate of 32.3%. The current year effective tax rate was primarily impacted by the effect of state and foreign taxes, offset by a research and development credit benefit. The prior year tax rate was impacted by the effect of state taxes, nondeductible stock compensation, and foreign taxes, offset by a research and development credit benefit. See Note 10, Income Taxes, of the Notes to Consolidated Financial Statements, included in this Annual Report on Form 10-K for more information.

14

Table of Contents

Net income was $20.2 million, or $3.55 per diluted share for the year ended June 30, 2025, compared to net income of $5.5 million, or $1.91 per diluted share in the prior year.

Liquidity and Capital Resources

Working capital (current assets less current liabilities) on June 30, 2026, was $82.7 million compared to $110.4 million on June 30, 2025. The $27.7 million decrease in working capital is primarily due to an increase in trade receivables of $7.4 million, an increase in inventories of $1.5 million, an increase in other current assets of $0.4 million, a decrease in other current liabilities of $1.4 million, and a decrease of insurance costs of $0.5 million partially offset by a decrease in cash of $23.3 million, an increase in accounts payable of $10.6 million, an increase in sales and advertising of $2.2 million, an increase in payroll and related items of $2.2 million and an increase in operating lease of $0.6 million. Capital expenditures were $3.9 milli

[Excerpt truncated for page length; the complete text is on the linked full-MD&A page.]

Read the full FY 2026 MD&A or browse all MD&A years.

MD&A history

Prior-year 10-K MD&A spans are extracted from SEC filings with the same bounded parser used for the latest filing. Each year's full verbatim text is on its own sub-page.

Macro cross-references for FLXS

Indicators mapped to this company's SIC classification (industry 2510 Household Furniture) by grepcent's deterministic macro-sector crosswalk. A navigational mapping, not a statistical or causal claim.

Macro-to-micro threads including this sector: Inflation (CPI / PCE / PPI), US labor market, Growth & output, Money & trade, Government finances, Sector employment, Industrial orders & inventories, Trade & external.

All 71 macro indicators →

For LLMs & downloads

Markdown twin: /company/FLXS.md · JSON record: /company/FLXS.json · verified financials: JSON / CSV · concise section index: /llms.txt